Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Nominations for 2016 National Academies Communication Awards For Excellence in Reporting and Communicating Sciences, Engineering, and Medicine, Keck Futures Initiative

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

• LPBI’s BioMed e-Series, 15 e-Books Titles in Medicine and Life Sciences on Amazon.com
• LPBI’s Open Access Online Scientific Journal, http://pharmaceuticalintelligence.com

Submission for Category: Online

From: <form_engine@fs22.formsite.com> on behalf of “commawards@nas.edu” <form_engine@fs22.formsite.com>

Reply-To: <commawards@nas.edu>

Date: Wednesday, January 27, 2016 at 3:25 PM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: 2016 Communication Awards Nomination Form Result #9076095

The National Academies of Sciences, Engineering, and Medicine



2016 Communication Awards 
For Excellence in Reporting and Communicating

Sciences, Engineering, and Medicine

Nomination Confirmation 

Thank you for submitting a nomination for the 2016 National Academies Communication Awards.

Please select the category of your nomination: *	Online
Online Entry Title: *	Cancer Biology & Genomics for Disease Diagnosis, Genomics Orientations for Personalized Medicine, Metabolic Genomics and Pharmaceutics, Milestones
Online Publisher(s): *	Leaders in Pharmaceutical Business Intelligence, BioMed e-Series http://pharmaceuticalintelligence.com/biomed-e-books/, Amazon.com
Online Publish Date: *	2015-08-11
Online Entry Summary (Please limit to 100 words): *	BioMed e-Series published in 2015 e-Books to popularize the Scientific findings of the frontier in Medicine and Life Sciences focusing on the top two Public HealthCare hazards: Cardiovascular Diseases and Cancer. The e-Series consists of medical interpretations of the most challenging causes of mortality and morbidities in Cancer Biology & Genomics for Disease Diagnosis, Genomics Orientations for Personalized Medicine, Metabolic Genomics and Pharmaceutics, the Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics, the Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics. Precision Medicine as in Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases.

ANNOUNCEMENT

Success – Thank You! Reference #: 9076095: The National Academies 2016 Communication Awards Nomination

I AM PROUD TO CONGRATULATE

• Larry H Bernstein, MD, FCAP
• Stephen J Williams, PhD
• Tilda Barliya, PhD
• Dror Nir, PhD

They constitute the TEAM that I nominated for 

The National Academies 2016 Communication Awards, Keck Futures Initiative – Nomination 

• Category: Online 
• Subject for Nomination: BioMed e-Series published in 2015 by Leaders in Pharmaceutical Business Intelligence on Amazon.com

BioMed e-Series

http://pharmaceuticalintelligence.com/biomed-e-books/

• Cancer Biology & Genomics for Disease Diagnosis,
• Genomics Orientations for Personalized Medicine,
• Metabolic Genomics and Pharmaceutics,
• Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics,
• Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics,
• Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases

100 words

BioMed e-Series published in 2015 e-Books to popularize the Scientific findings of the frontier in Medicine and Life Sciences focusing on the top two Public HealthCare hazards: Cardiovascular Diseases and Cancer. The e-Series consists of medical interpretations of the most challenging causes of mortality and morbidities in Cancer Biology & Genomics for Disease Diagnosis, Genomics Orientations for Personalized Medicine, Metabolic Genomics and Pharmaceutics, the Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics, the Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics. Precision Medicine as

https://fs22.formsite.com/res/showSuccessPage?EParam=m%2FOmK8apOTBRmouoTFrqiVATUbkBsVmGEQn3K0X14DG3VhR5CvnKsC1mzhLD6ne%2BXKN%2Fe20J%2FjE%3D

https://fs22.formsite.com/naseo-ca/2016_com_award_nom/index.html

Effective 1/27/2016

LPBI’s BioMed e-Series  was Submitted on 1/27/2016 for The National Academies of Sciences, Engineering, and Medicine



2016 Communication Awards 
For Excellence in Reporting and Communicating

Sciences, Engineering, and Medicine

The Keck Futures Initiative – a program of the National Academies of Sciences, Engineering, and Medicine, with the support of the W.M. Keck Foundation – will award four $20,000 prizes in 2016 to individuals or teams (up to four individuals associated with the creation of the work being nominated) who have developed creative, original works that address issues and advances in science, engineering and/or medicine for the general public. Nominations are accepted in four categories: Book; Film/Radio/TV; Magazine/Newspaper; and Online. The winners will be honored in the Fall 2016 and are expected to attend in person.

http://keckfutures.org/awards/nominate.html

 

Submission for Category: Magazine/Newspaper

From: <form_engine@fs22.formsite.com> on behalf of “commawards@nas.edu” <form_engine@fs22.formsite.com>

Reply-To: <commawards@nas.edu>

Date: Monday, February 1, 2016 at 11:37 AM

To: Aviva Lev-Ari <AvivaLev-Ari@alum.berkeley.edu>

Subject: 2016 Communication Awards Nomination Form Result #9101075

The National Academies of Sciences, Engineering, and Medicine



2016 Communication Awards 
For Excellence in Reporting and Communicating

Science, Engineering, and Medicine

Nomination Confirmation 

Thank you for submitting a nomination for the 2016 National Academies Communication Awards.

Please select the category of your nomination: *	Magazine/Newspaper
Publisher(s): *	Leaders in Pharmaceutical Business Intelligence – http://pharmaceuticalintelligence.com
Magazine/Newspaper Entry Summary (Please limit to 100 words): *	In February 2012, a new venture was launched Doing Business As (DBA) Leaders in Pharmaceutical Business Intelligence. Founder, Pharmaceutical Business Intelligence Services is Aviva Lev-Ari, PhD, RN.     An online scientific EXCHANGE — an Open Access Online Scientific Journal for curation and reporting on frontiers in Biomedical, Genomics, Biological Sciences, Healthcare Economics, Pharmacology, Pharmaceutical & Medicine. The website, http://pharmaceuticalintelligence.com a scientific, medical and business multi expert authoring environment in LIFE SCIENCES, PHARMACEUTICAL, HEALTHCARE & MEDICINE INDUSTRIES.   1,879 are following our Journal, 868,702 views, 7,175 scientific comments 4,068 Scientific Articles, 472 Categories of Research, 8,267 Tags — ALL that is BioTech !!!!!!!!

Success – Thank You! Reference #: 9101075: Category Magazine/Newspaper -The National Academies 2016 Communication Awards Nomination

I AM HAPPY YO SHARE WITH YOU THE NOMINATION OF OUR OPEN ACCESS ONLINE SCIENTIFIC JOURNAL 

http://pharmaceuticalintelligence.com

For The National Academies 2016 Communication Awards, Keck Futures Initiative – Nomination for

Excellence in Reporting and Communicating Science, Medicine and Engineering

• Category: Magazine/Newspaper
• Subject for Nomination: Journal published in 2015 by Leaders in Pharmaceutical Business Intelligence 

http://pharmaceuticalintelligence.com

100 words

In February 2012, a new venture was launched Doing Business As (DBA) Leaders in Pharmaceutical Business Intelligence. Founder, Pharmaceutical Business Intelligence Services is Aviva Lev-Ari, PhD, RN.

An online scientific EXCHANGE — an Open Access Online Scientific Journal for curation and reporting on frontiers in Biomedical, Genomics, Biological Sciences, Healthcare Economics, Pharmacology, Pharmaceutical & Medicine. The website,  http://pharmaceuticalintelligence.com a scientific, medical and business multi expert authoring environment in LIFE SCIENCES, PHARMACEUTICAL, HEALTHCARE & MEDICINE INDUSTRIES.

1,879 are following our Journal, 868,702 views, 7,175 scientific comments 4,068 Scientific Articles, 472 Categories of Research, 8,267 Tags — ALL that is BioTech !!!!!!!!

https://fs22.formsite.com/res/showSuccessPage?EParam=m%2FOmK8apOTBRmouoTFrqiVATUbkBsVmGEQn3K0X14DG3VhR5CvnKsC1mzhLD6ne%2BXKN%2Fe20J%2FjE%3D

https://fs22.formsite.com/naseo-ca/2016_com_award_nom/index.html

ANNOUNCEMENT

Effective 2/1/2016

LPBI’s http://pharmaceuticalintelligence.com was Submitted on 2/1/2016 to

2016 Communication Award – Excellence in Reporting and Communicating

Science, Medicine and Engineering

The Keck Futures Initiative – a program of the National Academies of Sciences, Engineering, and Medicine, with the support of the W.M. Keck Foundation – will award four $20,000 prizes in 2016 to individuals or teams (up to four individuals associated with the creation of the work being nominated) who have developed creative, original works that address issues and advances in science, engineering and/or medicine for the general public. Nominations are accepted in four categories: Book; Film/Radio/TV; Magazine/Newspaper; and Online. The winners will be honored in the Fall 2016 and are expected to attend in person.

http://keckfutures.org/awards/nominate.html

Submission for Category: Book

Nomination of e-Book, Series A: Cardiovascular Diseases, Volume 2, Cases in Development of Scientific Curation Methodology

2016 Communication Awards Nomination Form Result #9143807

 

The National Academies of Sciences, Engineering, and Medicine

2016 Communication Awards for Excellence in Reporting and Communicating Science, Medicine and Engineering

Nomination Confirmation 

 

Thank you for submitting a nomination for the 2016 National Academies Communication Awards. Below please find the supporting materials necessary for your nomination category, as well as the address to which they should be sent.

Please select the category of your nomination: *	Book
Book Title: *	Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation
Publisher(s): *	Amazon Kindle Direct
Publication Date: (Please select one): *	November 2015
Book Entry Summary (Please limit to 100 words): *	The explosion of scientific information has created difficulties tying together disparate discoveries, ideas, and potential applications. Pharmaceutical Business Intelligence is developing an innovative methodology for Global access to Biomedical knowledge rather than traditional search. To attain this complex goal they disseminate ORIGINAL Research via Content Curation by experts using critical thinking process & interpretation over open access networks, offering better organization and visibility of critical information useful for innovations in academic, clinical, and industrial research. Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation at http://www.amazon.com/dp/B018Q5MCN8 is nominated as an example of this methodology.
Are you nominating an individual or team (up to four individuals)? *	Team
Is this a self- or third-party nomination? *	Third-Party Nomination: I am nominating someone other than myself.
First Name *	Larry H
Last Name *	Bernstein, MD, FCAP
Title *	Chief Scientific Officer
Organization *	Leaders in Pharmaceutical Business Intelligence
Street Address	54 FIRETHORN LANE
City	NORTHAMPTON
State	MA
Postal Code	01060
Country	USA
E-Mail Address *	larry.bernstein@gmail.com
Phone Number *	4137278523
URL	http://pharmaceuticalintelligence.com
First Name	AVIVA
Last Name	Lev-Ari, PhD, RN
Organization	Leaders in Pharmaceutical Business Intelligence
E-Mail Address	avivalev-ari@alum.berkeley.edu
First Name	Justin D.
Last Name	Pearlman, MD, PhD, FACC
Organization	Leaders in Pharmaceutical Business Intelligence
E-Mail Address	jdmdphd@gmail.com
First Name *	Stephen J.
Last Name *	Williams, PhD
Title *	Editor
Organization *	Leaders in Pharmaceutical Business Intelligence
Street Address	7373 Ridge Avenue
Apt/Suite/Office	116
City	Philadelphia
State	PA
Postal Code	19128
Country	USA
E-Mail Address *	sjwilliamspa@comcast.net
Phone Number *	2154870259
URL	http://pharmaceuticalintelligence.com
How did you hear about this award? (Please check all that apply): *	Colleague/Word of Mouth Email Announcement Science 2.0 Science Online